The estimated Net Worth of Kenneth Di Pietro is at least 2.29 百万$ dollars as of 28 February 2017. Kenneth Pietro owns over 5,696 units of InVivo Therapeutics Corp stock worth over 2,643$ and over the last 13 years Kenneth sold NVIV stock worth over 2,283,452$.
Kenneth has made over 14 trades of the InVivo Therapeutics Corp stock since 2013, according to the Form 4 filled with the SEC. Most recently Kenneth exercised 5,696 units of NVIV stock worth 1,823$ on 28 February 2017.
The largest trade Kenneth's ever made was exercising 5,696 units of InVivo Therapeutics Corp stock on 28 February 2017 worth over 1,823$. On average, Kenneth trades about 1,183 units every 55 days since 2012. As of 28 February 2017 Kenneth still owns at least 8,260 units of InVivo Therapeutics Corp stock.
You can see the complete history of Kenneth Pietro stock trades at the bottom of the page.
Kenneth's mailing address filed with the SEC is C/O INVIVO THERAPEUTICS HOLDINGS CORP., ONE KENDALL SQUARE, SUITE B14402, CAMBRIDGE, MA, 02139.
Over the last 14 years, insiders at InVivo Therapeutics Corp have traded over 11,891,061$ worth of InVivo Therapeutics Corp stock and bought 364,908 units worth 191,940$ . The most active insiders traders include Francis Reynolds、Robert Langer、Sean F. Moran. On average, InVivo Therapeutics Corp executives and independent directors trade stock every 24 days with the average trade being worth of 10,438$. The most recent stock trade was executed by Brice Foose on 5 February 2023, trading 330,000 units of NVIV stock currently worth 122,100$.
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
InVivo Therapeutics Corp executives and other stock owners filed with the SEC include: